Drug Profile
Research programme: wound healing therapeutics - DelSite
Alternative Names: GelSite wound healing therapeutics - DelSiteLatest Information Update: 20 Oct 2009
Price :
$50
*
At a glance
- Originator DelSite Biotechnologies
- Class Growth factors
- Mechanism of Action Growth factor receptor agonists; Intercellular signalling peptide and protein stimulants; Protease stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Wounds
Most Recent Events
- 01 May 2007 Preclinical trials in Wounds in USA (Topical)